减少GABAA,缓慢的突触抑制在阿尔茨海默氏症的疾病
M Bruce MacIver1, Robert A Pearce2
1Stanford University School of Medicine, Stanford, CA, USA.
Journal of Alzheimer's disease : JAD
|March 21, 2025
概括
研究人员在老年阿尔茨海默病 (AD) 鼠标模型中发现缓慢的GABAergic抑制减少. 这种突触变化可能解释了阿兹海默症患者的记忆丧失和认知缺陷.
科学领域:
- 神经科学是一个神经科学.
- 突触生理学 突触生理学
- 阿尔茨海默氏症疾病研究研究
背景情况:
- 突触功能变化是阿尔茨海默病 (AD) 病理学的关键因素,导致记忆丧失和中枢神经系统 (CNS) 症状.
- 缓慢的胺黄油酸A型 (GABAA,缓慢) 突触电流的作用,是一种显著的神经元抑制形式,在AD中仍然在很大程度上没有特征.
研究的目的:
- 在阿尔茨海默病小鼠模型中研究GABAA,缓慢突触电流的生理变化.
- 为了确定这种特定抑制电流的变化是否与早期AD表现相关.
主要方法:
- 在海马大脑切片上进行了全细胞记录.
- 实验使用老年阿尔茨海默病模型小鼠 (tg-APPSwe),并将它们与野生型和非老年阿尔茨海默病小鼠进行比较.
主要成果:
- 在老年AD小鼠的牙状颗粒神经元中观察到GABAA,缓慢突触抑制的显著减少.
- 这种减少在成年非年龄的AD小鼠或野生类型的 littermates中并不存在.
结论:
- 在老年AD小鼠中减弱的GABAA,缓慢抑制可能是观察到的刺激-抑制不平衡的基础.
- 这一发现为早期的AD症状提供了潜在的细胞机制,例如受损的模式分离和改变的神经振荡.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
303
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
303
Acid Halides to Ketones: Gilman Reagent
2.7K
Lithium dialkyl cuprate, also known as Gilman reagents, selectively reduces acid halides to ketones. The acid chloride is treated with Gilman reagent at â78 °C in the presence of ether solution to produce a ketone in good yield.
As shown below, the mechanism proceeds in two steps. First, one of the alkyl groups of the reagent acts as a nucleophile and attacks the acyl carbon of the acid chloride to form a tetrahedral intermediate. This is followed by the reformation of the...
As shown below, the mechanism proceeds in two steps. First, one of the alkyl groups of the reagent acts as a nucleophile and attacks the acyl carbon of the acid chloride to form a tetrahedral intermediate. This is followed by the reformation of the...
2.7K
Sedatives and Hypnotics Drugs: Barbiturates
176
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
176
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.1K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.1K
G-protein Coupled Receptors
113.9K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
113.9K
G-Protein Gated Ion Channels
4.5K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
4.5K


